Broadway Dialysis Center At Elmhurst Hospital Center in Flushing, New York - Dialysis Center

Broadway Dialysis Center At Elmhurst Hospital Center is a medicare approved dialysis facility center in Flushing, New York and it has 25 dialysis stations. It is located in Queens county at 79-01 Broadway D-7 Wing, Flushing, NY, 11373. You can reach out to the office of Broadway Dialysis Center At Elmhurst Hospital Center at (718) 205-7772. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Broadway Dialysis Center At Elmhurst Hospital Center has the following ownership type - Profit. It was first certified by medicare in July, 2005. The medicare id for this facility is 332647 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBroadway Dialysis Center At Elmhurst Hospital Center
Location79-01 Broadway D-7 Wing, Flushing, New York
No. of Dialysis Stations 25
Medicare ID332647
Managed ByIndependent
Ownership TypeProfit
Late Shifts Yes

Contact Information


79-01 Broadway D-7 Wing, Flushing, New York, 11373
(718) 205-7772

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Broadway Dialysis Center At Elmhurst Hospital Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1063426377
Organization NameElmhurst Hospital Center
Doing Business AsNew York City Health And Hospitals Corporation
Address7901 Broadway Elmhurst, New York, 11373
Phone Number(718) 334-4900

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago


NPI Number1801883707
Organization NameBroadway Dialysis Center At Ehc
Doing Business AsNewton Dialysis Center
Address7901 Broadway Elmhurst, New York, 11373
Phone Number(718) 205-7772

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.60%67%
Patients who reported that nephrologists usually communicated and cared for them.11%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.29%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).52%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).23%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).25%14%

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.51%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.19%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.30%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).46%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).38%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).16%12%

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 75%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.25%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).51%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).32%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).17%12%

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data46
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL35

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center116
    Adult patient months included in Kt/V greater than or equal to 1.21088
    Percentage of adult patients getting regular hemodialysis at the center95
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

    Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

    Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

    The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

    Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

    OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

    Researchers develop series of techniques to create active iron-based catalysts

    University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

    Read more Medical News

    › Verified 1 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center25
    Adult patient months included in Kt/V greater than or equal to 1.7240
    Percentage of adult patients getting regular peritoneal dialysis at the center11
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

    Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

    Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

    The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

    Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

    OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

    Researchers develop series of techniques to create active iron-based catalysts

    University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Broadway Dialysis Center At Elmhurst Hospital Center with elevated calcium levels.

Patients with hypercalcemia142
Hypercalcemia patient months1392
Hypercalcemia patients with serumcalcium greater than 10.2 mg2
Patients with Serumphosphor138
Patients with Serumphosphor less than 3.5 mg/dL12
Patients with Serumphosphor from 3.5 to 4.5 mg/dL24
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL26
Patients with Serumphosphor greater than 7 mg/dL10

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 58
Patient months included in arterial venous fistula and catheter summaries 542
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment79
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer7

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary83
Hospitalization Rate in facility165.5 (As Expected)
Hospitalization Rate: Upper Confidence Limit294.7
Hospitalization Rate: Lower Confidence Limit101.4

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Broadway Dialysis Center At Elmhurst Hospital Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility36.8 (As Expected)
Readmission Rate: Upper Confidence Limit54.7
Readmission Rate: Lower Confidence Limit22

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Broadway Dialysis Center At Elmhurst Hospital Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.77 (As Expected)
SIR: Upper Confidence Limit1.46
SIR: Lower Confidence Limit.36

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Broadway Dialysis Center At Elmhurst Hospital Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 77
Transfusion Rate in facility12.1 (As Expected)
Transfusion Rate: Upper Confidence Limit51.2
Transfusion Rate: Lower Confidence Limit3.4

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Broadway Dialysis Center At Elmhurst Hospital Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary573
Mortality Rate in facility9.5 (Better than Expected)
Mortality Rate: Upper Confidence Limit13.7
Mortality Rate: Lower Confidence Limit6.3

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago


Dialysis Facility in Flushing, NY

THE Ny Hosp Med Ctr Of Queens
Location: 56-45 Main Street, Flushing, New York, 11355
Phone: (718) 670-1258
Usrc South Flushing
Location: 71-12 Park Avenue, Flushing, New York, 11365
Phone: (718) 591-4010
Broadway Dialysis Center At Elmhurst Hospital Center
Location: 79-01 Broadway D-7 Wing, Flushing, New York, 11373
Phone: (718) 205-7772
CRD Associates Llc Cliffside Nursing Home
Location: 119-19 Graham Court, Flushing, New York, 11354
Phone: (718) 886-0700
Queens Dialysis At The Pavilion, Llc
Location: 36-17 Parsons Blvd, Flushing, New York, 11354
Phone: (718) 888-5200

News Archive

Gov. O'Malley signs two bills that set new rules for no-cost, low-cost hospital care, financial information

Maryland Gov. Martin O'Malley (D) signed two bills on Thursday that institute new rules to determine eligibility for no-cost or reduced-price care at state hospitals and mandate that staff provide financial assistance information to all patients, the Baltimore Sun reports.

Accumulation of plaques in brain may serve as powerful biomarker for early detection of cognitive decline

The trajectory of amyloid plaque buildup-clumps of abnormal proteins in the brain linked to Alzheimer's disease-may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine's Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging.

Peer-reviewed articles elucidate role of clusterin in promoting tumor resistance to cancer treatment

OncoGenex Pharmaceuticals, Inc., announced today that two peer-reviewed articles have been published that further elucidate the biological function of clusterin, its role in promoting tumor resistance to cancer treatment, and the role of an inhibitor of clusterin such as custirsen (OGX-011) that is designed to knock down treatment resistance in the cells and enhance the effectiveness of cancer therapies.

Researchers develop series of techniques to create active iron-based catalysts

University of Toronto researchers have developed a series of techniques to create a variety of very active iron-based catalysts necessary to produce the alcohols and amines used in the drug and perfume industry. The new synthetic methods promise to be safer and more economical and environmentally friendly than traditional industrial processes.

Read more Medical News

› Verified 1 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.